SNSE (Sensei Biotherapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings

Sensei Biotherapeutics, Inc. Common Stock (SNSE) is a publicly traded Healthcare sector company. As of May 21, 2026, SNSE trades at $17.58 with a market cap of $26.70M and a P/E ratio of -1.04. SNSE moved +4.59% today. Year to date, SNSE is +80.68%; over the trailing twelve months it is +167.91%. Its 52-week range spans $5.00 to $36.76. Rallies surfaces SNSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SNSE?

The average price target is $0.00.

SNSE Key Metrics

Key financial metrics for SNSE
MetricValue
Price$17.58
Market Cap$26.70M
P/E Ratio-1.04
EPS$-16.72
Dividend Yield0.00%
52-Week High$36.76
52-Week Low$5.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-21.09M
Gross Margin0.00%

SNSE Analyst Consensus

SNSE analyst coverage data. Average price target: $0.00.

Latest SNSE News

Recent SNSE Insider Trades

  • MILLENNIUM MANAGEMENT LLC bought 1.11K (~$36.99K) on Apr 7, 2026.
  • MILLENNIUM MANAGEMENT LLC sold 2.12K (~$61.21K) on Apr 7, 2026.
  • MILLENNIUM MANAGEMENT LLC sold 205 (~$6.09K) on Apr 7, 2026.

Common questions about SNSE

What do analysts rate SNSE?
The average price target is $0.00.
Does Rallies show SNSE price targets?
Yes. Rallies tracks SNSE analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SNSE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNSE. It does not provide personalized investment advice.
SNSE

SNSE